Investor Relations
Data provided by TradingView. Exchange: XETRA | Ticker: T9G
Aktieninformationen
- Symbol
- T9G
- ISIN
- GB00BM9XQ619
- WKN
- A3DTUQ
- LEI
- 875500BCH1T6XX5EUG13
- Börsen
- Hamburg · Stuttgart · Düsseldorf
- Handelssysteme
- Xetra · Tradegate
- Kontakt
- investors@vidacpharma.com
Investitions-Highlights
- ✓USD 22,8 Mio. von privaten Investoren investiert seit 2012
- ✓USD 4,9 Mio. von CSO- und Innovationsbehörden investiert
- ✓Notiert an drei deutschen Börsen unter BaFin-Genehmigung
- ✓Gewinner des Seal of Excellence von Horizon Europe EIC
- ✓Management-Buyout durch Herzberg und Richter im Jahr 2019
Finanzkalender
Upcoming
Audited annual consolidated financial report (year ended 31 Dec 2025)
Quest entry decision expected
Unaudited interim financial statements (six months ended 30 June 2026)
HealthTech Innovation Days
Paris, France
Past Events
19th Annual European Life Sciences CEO Forum — Sachs Associates (attendance cancelled)
Zurich, Switzerland
11th ILANIT / FISEB Conference
Eilat, Israel
First patient dosed in Phase 2B trial
Virtual investor conference (850 attendees)
Phase 2B trial initiation at CentroDerm (Germany)
Germany
Prospectus publication
Düsseldorf Stock Exchange application
18th Annual European Life Sciences CEO Forum — Sachs Associates
Zurich, Switzerland
Eilat Symposium on Pediatric Cancer — Compassionate Use Presentation
Eilat, Israel
Annual Report 2024 publication
17th Annual European Life Sciences CEO Forum — Sachs Associates
Zurich, Switzerland
Annual Report 2023 publication
HealthTech Innovation Days (HTID)
Israel
Dokumente & Berichte
Securities Prospectus
Annual Reports
Interim Reports
Corporate Governance
Analyst Coverage
- 📄
Sphene Capital — Initiation Report (Jun 2024)
2024-06-01
- 📄
Sphene Capital — Update Report (Jul 2024)
2024-07-01
- 📄
Sphene Capital — Update Report (Nov 2024)
2024-11-20
- 📄
Sphene Capital — IP Valuation Analysis (Feb 2025)
2025-02-01
- 📄
Sphene Capital — Update Report (Jun 2025)
2025-06-01
- 📄
Sphene Capital — Update Report (Aug 2025)
2025-08-01
- 📄
Sphene Capital — Update Report (Nov 2025)
2025-11-01